EUROMED AG
EUROMED AG english
Audited 2001 annual financial statements adjusted to the plus side
Ad-hoc-announcement transmitted by DGAP.
The issuer is solely responsible for the content of this announcement.
——————————————————————————–
Fürth, March 28, 2002
EUROMED AG (Neuer Markt: EUD) has announced that according to the annual
financial statements approved by the supervisory board and published
on February 18, 2002, the preliminary basic figures for fiscal year 2001 have
changed. According to the audited figures, the reported earnings before interest
and taxes (EBIT) have increased from preliminary EBIT of EUR 150,000 to EUR
284,000. At the end of fiscal year 2000, the Company reported negative EBIT of
EUR -1,602,000.
Final consolidated sales totaled EUR 19,493,000. Because of reclassifications,
prior-year sales were adjusted pro forma, resulting in a 24.4% increase in year-
over-year sales instead of the preliminarily reported 21.8%.
Long-term Company financing has been secured by the commitment of a EUR 6
million line of credit dated March 26, 2002. This financing is not reported in
the approved annual financial statements.
For the current fiscal year, EUROMED AG anticipates sales to rise to
approximately EUR 20 million. Actions taken to reduce costs will play a large
part in achieving this result.
Contact:
Harald Niebler, Investor Relations, EUROMED AG,
Tel: 0911 9714-604; Fax: 0911 9714-607; e-mail: hniebler@euromed.de
end of ad-hoc-announcement (c)DGAP 28.03.2002
——————————————————————————–
WKN: 570680; ISIN: DE0005706808; Index:
Listed: Neuer Markt in Frankfurt; Freiverkehr in Berlin, Bremen, Düsseldorf,
Hamburg, Hannover, München und Stuttgart
280659 Mär 02
Aktuelle News
Aktuelle Berichte
Keine Berichte gefunden
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden